CN101001535B - 经过茶原料叶和枇杷叶的揉搓加工得到的发酵茶及以发酵茶中含有的萃取物为有效成分的组成物 - Google Patents
经过茶原料叶和枇杷叶的揉搓加工得到的发酵茶及以发酵茶中含有的萃取物为有效成分的组成物 Download PDFInfo
- Publication number
- CN101001535B CN101001535B CN2005800260065A CN200580026006A CN101001535B CN 101001535 B CN101001535 B CN 101001535B CN 2005800260065 A CN2005800260065 A CN 2005800260065A CN 200580026006 A CN200580026006 A CN 200580026006A CN 101001535 B CN101001535 B CN 101001535B
- Authority
- CN
- China
- Prior art keywords
- tea
- leaf
- raw material
- rubbing
- fermented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013616 tea Nutrition 0.000 title claims abstract description 194
- 235000019225 fermented tea Nutrition 0.000 title claims abstract description 74
- 238000012545 processing Methods 0.000 title claims description 96
- 239000000203 mixture Substances 0.000 title abstract description 29
- 244000269722 Thea sinensis Species 0.000 title description 204
- 235000009008 Eriobotrya japonica Nutrition 0.000 title description 18
- 239000000463 material Substances 0.000 title description 6
- 244000061508 Eriobotrya japonica Species 0.000 title 1
- 238000005096 rolling process Methods 0.000 title 1
- 239000002994 raw material Substances 0.000 claims abstract description 105
- 238000001035 drying Methods 0.000 claims abstract description 16
- 241001122767 Theaceae Species 0.000 claims abstract 27
- 238000000855 fermentation Methods 0.000 claims description 79
- 230000004151 fermentation Effects 0.000 claims description 79
- 210000004369 blood Anatomy 0.000 claims description 46
- 239000008280 blood Substances 0.000 claims description 46
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 31
- 239000008103 glucose Substances 0.000 claims description 31
- 239000003205 fragrance Substances 0.000 claims description 29
- 239000002699 waste material Substances 0.000 claims description 29
- 206010012601 diabetes mellitus Diseases 0.000 claims description 26
- 210000002966 serum Anatomy 0.000 claims description 25
- 239000000470 constituent Substances 0.000 claims description 23
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 19
- 239000004480 active ingredient Substances 0.000 claims description 17
- 230000007935 neutral effect Effects 0.000 claims description 15
- 210000000577 adipose tissue Anatomy 0.000 claims description 14
- -1 lipid peroxide Chemical class 0.000 claims description 13
- 230000009467 reduction Effects 0.000 claims description 11
- 235000001497 healthy food Nutrition 0.000 claims description 10
- 238000004898 kneading Methods 0.000 claims description 10
- 235000013361 beverage Nutrition 0.000 claims description 9
- 235000012000 cholesterol Nutrition 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 4
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 80
- 235000013305 food Nutrition 0.000 description 55
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 44
- 238000000605 extraction Methods 0.000 description 34
- 239000000843 powder Substances 0.000 description 28
- 235000009569 green tea Nutrition 0.000 description 23
- 235000006468 Thea sinensis Nutrition 0.000 description 18
- 241001092070 Eriobotrya Species 0.000 description 17
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 17
- 235000005487 catechin Nutrition 0.000 description 17
- 230000005764 inhibitory process Effects 0.000 description 17
- 235000020279 black tea Nutrition 0.000 description 15
- 229950001002 cianidanol Drugs 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 15
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 14
- 230000002401 inhibitory effect Effects 0.000 description 14
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 13
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 13
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 11
- 239000001573 invertase Substances 0.000 description 11
- 235000011073 invertase Nutrition 0.000 description 11
- IPMYMEWFZKHGAX-ZKSIBHASSA-N theaflavin Chemical compound C1=C2C([C@H]3OC4=CC(O)=CC(O)=C4C[C@H]3O)=CC(O)=C(O)C2=C(O)C(=O)C=C1[C@@H]1[C@H](O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-ZKSIBHASSA-N 0.000 description 11
- IPMYMEWFZKHGAX-UHFFFAOYSA-N Isotheaflavin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(C1=C2)=CC(O)=C(O)C1=C(O)C(=O)C=C2C1C(O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-UHFFFAOYSA-N 0.000 description 10
- UXRMWRBWCAGDQB-UHFFFAOYSA-N Theaflavin Natural products C1=CC(C2C(CC3=C(O)C=C(O)C=C3O2)O)=C(O)C(=O)C2=C1C(C1OC3=CC(O)=CC(O)=C3CC1O)=CC(O)=C2O UXRMWRBWCAGDQB-UHFFFAOYSA-N 0.000 description 10
- 230000037396 body weight Effects 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 235000014620 theaflavin Nutrition 0.000 description 10
- 229940026509 theaflavin Drugs 0.000 description 10
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 9
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 9
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 9
- 229940074393 chlorogenic acid Drugs 0.000 description 9
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 9
- 235000001368 chlorogenic acid Nutrition 0.000 description 9
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 9
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 8
- 240000003152 Rhus chinensis Species 0.000 description 7
- 235000014220 Rhus chinensis Nutrition 0.000 description 7
- 230000003647 oxidation Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- 230000002265 prevention Effects 0.000 description 7
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 5
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 5
- 235000019658 bitter taste Nutrition 0.000 description 5
- 230000001186 cumulative effect Effects 0.000 description 5
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 5
- 235000012734 epicatechin Nutrition 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 4
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000003064 anti-oxidating effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 4
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 3
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000508269 Psidium Species 0.000 description 3
- 229960002632 acarbose Drugs 0.000 description 3
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 3
- 230000001174 ascending effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 235000003642 hunger Nutrition 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- QEGNUYASOUJEHD-UHFFFAOYSA-N 1,1-dimethylcyclohexane Chemical compound CC1(C)CCCCC1 QEGNUYASOUJEHD-UHFFFAOYSA-N 0.000 description 2
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 240000001548 Camellia japonica Species 0.000 description 2
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 150000001765 catechin Chemical class 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000018597 common camellia Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- KSMVZQYAVGTKIV-UHFFFAOYSA-N decanal Chemical compound CCCCCCCCCC=O KSMVZQYAVGTKIV-UHFFFAOYSA-N 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 229940030275 epigallocatechin gallate Drugs 0.000 description 2
- 230000007760 free radical scavenging Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 2
- 231100000636 lethal dose Toxicity 0.000 description 2
- NUJGJRNETVAIRJ-UHFFFAOYSA-N octanal Chemical compound CCCCCCCC=O NUJGJRNETVAIRJ-UHFFFAOYSA-N 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- SGAWOGXMMPSZPB-UHFFFAOYSA-N safranal Chemical compound CC1=C(C=O)C(C)(C)CC=C1 SGAWOGXMMPSZPB-UHFFFAOYSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 1
- HJDZTDLMEBIHJJ-ZIRGRKGMSA-N (3E,5E)-nona-1,3,5-triene Chemical compound CCC\C=C\C=C\C=C HJDZTDLMEBIHJJ-ZIRGRKGMSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- XYTKCJHHXQVFCK-UHFFFAOYSA-N 1,3,8-trimethylnaphthalene Chemical compound CC1=CC=CC2=CC(C)=CC(C)=C21 XYTKCJHHXQVFCK-UHFFFAOYSA-N 0.000 description 1
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 1
- HFDVRLIODXPAHB-UHFFFAOYSA-N 1-tetradecene Chemical group CCCCCCCCCCCCC=C HFDVRLIODXPAHB-UHFFFAOYSA-N 0.000 description 1
- 241000758794 Asarum Species 0.000 description 1
- 244000007668 Cassia auriculata Species 0.000 description 1
- 235000007436 Cassia auriculata Nutrition 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 239000004470 DL Methionine Substances 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 235000013717 Houttuynia Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000016357 Mirtillo rosso Nutrition 0.000 description 1
- 101000869659 Mus musculus Relaxin receptor 2 Proteins 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 229930185110 Theasinensin Natural products 0.000 description 1
- YUULFXAQUWEYNP-UHFFFAOYSA-N Theasinensin D Natural products C=1C(O)=C(O)C(O)=C(C=2C(=CC(O)=C(O)C=2O)C2C(CC3=C(O)C=C(O)C=C3O2)OC(=O)C=2C=C(O)C(O)=C(O)C=2)C=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 YUULFXAQUWEYNP-UHFFFAOYSA-N 0.000 description 1
- 244000077923 Vaccinium vitis idaea Species 0.000 description 1
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 108010042362 beta-Lipotropin Proteins 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000003808 methanol extraction Methods 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 108700011006 mouse mighty Proteins 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- SBNFWQZLDJGRLK-UHFFFAOYSA-N phenothrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 SBNFWQZLDJGRLK-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000017509 safranal Nutrition 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960002668 sodium chloride Drugs 0.000 description 1
- 238000002470 solid-phase micro-extraction Methods 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052613 tourmaline Inorganic materials 0.000 description 1
- 229940070527 tourmaline Drugs 0.000 description 1
- 239000011032 tourmaline Substances 0.000 description 1
- GXPHKUHSUJUWKP-UHFFFAOYSA-N troglitazone Chemical compound C1CC=2C(C)=C(O)C(C)=C(C)C=2OC1(C)COC(C=C1)=CC=C1CC1SC(=O)NC1=O GXPHKUHSUJUWKP-UHFFFAOYSA-N 0.000 description 1
- 229960001641 troglitazone Drugs 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/12—Rolling or shredding tea leaves
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/08—Oxidation; Fermentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Tea And Coffee (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
试样 | 麦芽糖酶抑制率(%) | 转化酶抑制率(%) |
绿茶 | 61.2 | 61.3 |
枇杷叶 | 55.4 | 58.5 |
番石榴茶 | 48.3 | 38.3 |
红茶 | 55.6 | 52.7 |
试样 | 清除活性(mmol-Trolox/mg) |
绿茶 | 1.6 |
试样 | 清除活性(mmol-Trolox/mg) |
枇杷叶 | 0.3 |
番石榴茶 | 1.1 |
阿卡波糖 | 3.1 |
ラナワナ | 4.9 |
萃取物浓度 | 总血糖值面积(AUC0-120) | 总血糖值面积的下降率(%) |
控制 | 130.5±4.8mg/h/dL | - |
10mg/kg | 102.5±12.8mg/h/dL | 21.9 |
20mg/kg | 82.5±6.5mg/h/dL | 36.8 |
试样 | 胰岛素浓度(ng/ml) |
LETO-控制食物 | 7.30 |
OLETF-控制食物 | 3.68 |
OLETF-粉末荒茶食物 | 8.18 |
OLETF-粉末枇杷叶食物 | 3.12 |
试样 | 胰岛素浓度(ng/ml) |
OLETF-粉末揉搓加工发酵茶叶食物 | 7.75 |
试样 | 血清过氧化脂质浓度(nmol/ml) |
LETO-控制食物 | 11.86 |
OLETF-控制食物 | 63.78 |
OLETF-粉末荒茶食物 | 92.83 |
OLETF-粉末枇杷叶食物 | 78.57 |
OLETF-粉末揉搓加工发酵茶叶食物 | 35.23 |
试样 | 脂肪组织重量(g) |
LETO-控制食物 | 38.2 |
OLETF-控制食物 | 131.1 |
OLETF-粉末荒茶食物 | 77.1 |
OLETF-粉末枇杷叶食物 | 80.1 |
OLETF-粉末揉搓加工发酵茶叶食物 | 76.8 |
试样 | 血清胆固醇(mg/dl) | 血清甘油三脂(mg/dl) | 肝脏胆固醇(mg/g) | 肝脏甘油三脂(mg/g) |
LETO-控制食物 | 147 | 55.6 | 3.28 | 9.78 |
OLETF-控制食物 | 253 | 234 | 5.98 | 49.5 |
OLETF-粉末荒茶食物 | 183 | 127 | 3.43 | 16.9 |
OLETF-粉末枇杷叶食物 | 238 | 237 | 4.90 | 34.1 |
OLETF-粉末揉搓加工发酵茶叶食物 | 177 | 139 | 3.08 | 12.6 |
试样 | 胰岛素浓度(ng/ml) |
LETO-控制食物 | 7.82 |
OLETF-控制食物 | 3.10 |
OLETF-荒茶食物 | 2.75 |
OLETF-枇杷叶食物 | 2.55 |
OLETF-揉搓加工发酵茶叶食物 | 8.33 |
试样 | 脂肪组织重量(g) |
LETO-控制食物 | 37.0 |
OLETF-控制食物 | 125.0 |
OLETF-荒茶食物 | 115.8 |
OLETF-枇杷叶食物 | 110.2 |
OLETF-揉搓加工发酵茶叶食物 | 94.7 |
试样 | 血清甘油三脂(mg/dl) | 肝脏甘油三脂(mg/g) |
LETO-控制食物 | 70.1 | 12.4 |
OLETF-控制食物 | 290 | 88.8 |
OLETF-荒茶食物 | 278 | 105.5 |
OLETF-枇杷叶食物 | 312 | 74.3 |
OLETF-揉搓加工发酵茶叶食物 | 170 | 43.9 |
Claims (13)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004227142 | 2004-08-03 | ||
JP227142/2004 | 2004-08-03 | ||
JP2005002583 | 2005-01-07 | ||
JP002583/2005 | 2005-01-07 | ||
PCT/JP2005/014129 WO2006013866A1 (ja) | 2004-08-03 | 2005-08-02 | 茶の原料葉とビワ葉の揉捻加工による発酵茶及び発酵茶に含有される抽出物を有効成分とする組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101001535A CN101001535A (zh) | 2007-07-18 |
CN101001535B true CN101001535B (zh) | 2010-10-13 |
Family
ID=35787149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2005800260065A Active CN101001535B (zh) | 2004-08-03 | 2005-08-02 | 经过茶原料叶和枇杷叶的揉搓加工得到的发酵茶及以发酵茶中含有的萃取物为有效成分的组成物 |
Country Status (4)
Country | Link |
---|---|
US (1) | US7901724B2 (zh) |
JP (1) | JP4701327B2 (zh) |
CN (1) | CN101001535B (zh) |
WO (1) | WO2006013866A1 (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4974116B2 (ja) * | 2005-06-27 | 2012-07-11 | 国立大学法人 鹿児島大学 | ビワ葉抽出物を含有する飲食品及び医薬品 |
JP4701328B2 (ja) * | 2006-02-02 | 2011-06-15 | 長崎県 | 発酵茶葉およびその製造方法、発酵茶葉抽出物ならびに飲食品 |
PL2096937T3 (pl) * | 2006-12-01 | 2011-06-30 | Unilever Nv | Sposób wytwarzania produktów herbacianych o zwiększonej zawartości teaflawiny |
JP2009221158A (ja) * | 2008-03-17 | 2009-10-01 | Nagasaki Prefecture | 中性脂肪低減剤および体脂肪増加抑制剤 |
JP4704448B2 (ja) * | 2008-03-28 | 2011-06-15 | 農業生産法人 有限会社十津川農場 | 養殖魚介類用飼料 |
JP5232979B2 (ja) * | 2009-02-18 | 2013-07-10 | 長崎県 | コレステロール低減剤 |
KR101416492B1 (ko) | 2012-07-25 | 2014-07-16 | 최영욱 | 대추잎과 녹차잎을 이용한 혼합 발효차 및 그 제조방법 |
CN103583729B (zh) * | 2013-09-16 | 2015-07-22 | 中国农业科学院茶叶研究所 | 一种果味红茶浓缩汁的加工方法 |
CN104171192B (zh) * | 2014-08-09 | 2016-06-15 | 刘永 | 一种枇杷茶的制作方法 |
CN104705460B (zh) * | 2015-04-09 | 2018-01-05 | 陈娜卿 | 一种枇杷叶茶及其加工方法 |
CN106900944B (zh) * | 2017-03-01 | 2021-03-16 | 南通市天籁村农业科技发展有限公司 | 一种益生菌发酵的即冲枇杷叶袋泡茶的制备方法 |
KR102394666B1 (ko) * | 2017-11-09 | 2022-05-06 | (주)아모레퍼시픽 | 발효녹차 추출물의 제조방법 및 이로부터 제조된 발효녹차 추출물 |
CN109329510A (zh) * | 2018-11-13 | 2019-02-15 | 广东省农业科学院茶叶研究所 | 一种烘干沉香黄茶及其加工方法 |
JP6807483B1 (ja) * | 2019-12-27 | 2021-01-06 | サントリーホールディングス株式会社 | オフフレーバーが低減された緑茶飲料 |
CN111227064A (zh) * | 2020-03-14 | 2020-06-05 | 中茶科技(北京)有限公司 | 一种家用轻便茶叶发酵工艺及设备 |
CN111838370B (zh) * | 2020-07-29 | 2023-02-03 | 周丽生 | 一种具有调理脾胃、清热排毒的酸角叶药茶及其生产工艺 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1107312A (zh) * | 1994-02-23 | 1995-08-30 | 李宗相 | 一种可直接冲泡的枇杷茶制作方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0736742B2 (ja) * | 1989-02-01 | 1995-04-26 | 喜市 本田 | 多種配合茶及びその抽出茶液 |
JPH03266954A (ja) * | 1990-03-16 | 1991-11-27 | Yoshiko Goto | ビワ茶のティーバッグ用製造方法 |
CN1086669A (zh) * | 1992-11-11 | 1994-05-18 | 李宗相 | 一种保健枇杷茶及其配制方法 |
CN1093229A (zh) * | 1993-04-04 | 1994-10-12 | 李宗相 | 一种保健枇杷茶及其配制方法 |
CN1083315A (zh) * | 1993-04-05 | 1994-03-09 | 李宗相 | 保健枇杷茶饮料及其制作方法 |
CN1051442C (zh) * | 1995-12-04 | 2000-04-19 | 成云开 | 保健擂茶浆料及其制作方法 |
JP3188951B2 (ja) * | 1997-12-10 | 2001-07-16 | 正美 出口 | 枇杷茶 |
JP3452351B2 (ja) | 1999-06-04 | 2003-09-29 | 十津川株式会社 | ビワ茶の製造設備 |
JP2001069917A (ja) * | 1999-09-02 | 2001-03-21 | Hayakawa Koso Inryo Kenkyusho:Kk | オリーブ葉入り茶 |
JP3445567B2 (ja) * | 2000-08-31 | 2003-09-08 | 株式会社東洋新薬 | 健康茶および健康飲料並びにその製造方法 |
JP2002095415A (ja) * | 2000-09-21 | 2002-04-02 | Usaien Seiyaku Kk | テアフラビン類の製造方法 |
US7227014B2 (en) * | 2001-08-07 | 2007-06-05 | Isis Pharmaceuticals, Inc. | Antisense modulation of apolipoprotein (a) expression |
WO2003022066A1 (en) * | 2001-09-12 | 2003-03-20 | Unilever Plc | Tea manufacture |
JP2003128571A (ja) * | 2001-10-22 | 2003-05-08 | Matsuura Yakugyo Kk | 糖尿病医薬および健康食品 |
JP3590029B2 (ja) | 2002-02-08 | 2004-11-17 | 花王株式会社 | 発酵茶飲料、半発酵茶飲料の製造法 |
JP2003289834A (ja) * | 2002-04-01 | 2003-10-14 | Fujimori:Kk | ノニ葉茶およびその抽出茶液 |
JP2004105036A (ja) * | 2002-09-17 | 2004-04-08 | Marusada Seicha Kk | 漢方茶の製造方法 |
JP2004141056A (ja) * | 2002-10-24 | 2004-05-20 | Meiji Seika Kaisha Ltd | 酸化還元酵素及び細胞壁消化酵素を用いた発酵茶製品の製造方法 |
-
2005
- 2005-08-02 JP JP2006531501A patent/JP4701327B2/ja active Active
- 2005-08-02 CN CN2005800260065A patent/CN101001535B/zh active Active
- 2005-08-02 WO PCT/JP2005/014129 patent/WO2006013866A1/ja active Application Filing
-
2007
- 2007-02-01 US US11/670,360 patent/US7901724B2/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1107312A (zh) * | 1994-02-23 | 1995-08-30 | 李宗相 | 一种可直接冲泡的枇杷茶制作方法 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2006013866A1 (ja) | 2008-05-01 |
CN101001535A (zh) | 2007-07-18 |
US7901724B2 (en) | 2011-03-08 |
WO2006013866A1 (ja) | 2006-02-09 |
JP4701327B2 (ja) | 2011-06-15 |
US20070190219A1 (en) | 2007-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101001535B (zh) | 经过茶原料叶和枇杷叶的揉搓加工得到的发酵茶及以发酵茶中含有的萃取物为有效成分的组成物 | |
Cabrera et al. | Beneficial effects of green tea—a review | |
Xu et al. | The effects of the aqueous extract and residue of Matcha on the antioxidant status and lipid and glucose levels in mice fed a high-fat diet | |
EA020639B1 (ru) | Способ производства чайных продуктов | |
CN101683165B (zh) | 用于抑制血糖值上升的组合物以及饮食品 | |
KR20110068958A (ko) | 지치 추출물을 유효성분으로 하는 비만개선용 약제학적 조성물 | |
KR101076535B1 (ko) | 지치 추출물을 유효성분으로 하는 숙취해소용 식품조성물 | |
JP4314293B2 (ja) | 機能性食品組成物 | |
Abdelaleem et al. | Chemical, technological and biological evaluation of mulberry and persimmon leaves | |
KR101134251B1 (ko) | 사상자 추출물을 유효성분으로 하는 비만개선용 식품조성물 | |
KR101076185B1 (ko) | 토마토 전초 추출물을 유효성분으로 하는 지방간 개선용 약제학적 조성물 | |
JP2005137210A (ja) | 茶類と長命草の調製物又は抽出物を含む組成物 | |
JP2009221158A (ja) | 中性脂肪低減剤および体脂肪増加抑制剤 | |
Wang et al. | Antioxidative effect of large molecular polymeric pigments extracted from zijuan pu-erh tea in vitro and in vivo | |
JP5769994B2 (ja) | 茶製品の製造方法 | |
KR101146115B1 (ko) | 항암 및 항산화 활성을 가진 옻나무 발효추출물을 포함하는 음료 및 이의 제조 방법 | |
KR101076583B1 (ko) | 지치 추출물을 유효성분으로 하는 지방간 개선용 식품조성물 | |
CN108367035A (zh) | 多酚吸收促进剂 | |
JP2003204787A (ja) | 糖分生産酵素抑制剤及びそれを含む組成物 | |
JP2007269677A (ja) | 糖化ヘモグロビン上昇抑制剤 | |
EP2922558B1 (en) | Composition comprising theanine and an extract of inula racemosa | |
Ryan | Anti-Diabetic and Anti-Obesity Activities of Cocoa (Theobroma cacao) via Physiological Enzyme Inhibition | |
KR101076575B1 (ko) | 토마토 전초 추출물을 유효성분으로 하는 비만개선용 식품조성물 | |
KR101076536B1 (ko) | 토마토 전초 추출물을 유효성분으로 하는 숙취해소용 식품조성물 | |
KR101076098B1 (ko) | 토마토 전초 추출물을 유효성분으로 하는 숙취해소용 약제학적 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CI01 | Publication of corrected invention patent application |
Correction item: Abstract of the description|Abstract figure Correct: Correct False: Error Number: 41 Volume: 26 |
|
CI02 | Correction of invention patent application |
Correction item: Abstract of the description|Abstract figure|Claims|Description|Drawings Correct: Correct False: Error Number: 41 Volume: 26 |
|
ERR | Gazette correction |
Free format text: CORRECT: ABSTRACT OF DESCRIPTION; FIGURE OF ABSTRACT; FROM: ERROR TO: CORRECT |
|
RECT | Rectification | ||
CI03 | Correction of invention patent |
Correction item: Drawings Correct: Correct False: Error Number: 41 Page: Description Volume: 26 |
|
RECT | Rectification | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181212 Address after: Nagasaki County, Japan Co-patentee after: Nagasaki Prefectural University Corporation Patentee after: Chang Qixian Address before: Nagasaki County, Japan Co-patentee before: Nagasaki Prefectural University Corporation Patentee before: Chang Qixian Co-patentee before: Juristic Person of Nagasaki Public University Co-patentee before: Kyushu University |